Specialized expertise and comprehensive laboratory services to advance cardiovascular disease research and therapeutic development.
Comprehensive infectious disease testing for vaccines, antivirals & therapeutics with advanced diagnostics & regulatory-compliant support.
Comprehensive lab capabilities for metabolic disease research, including biomarkers, LC-MS/MS, immunoassays, and genomics for high-impact data.
Expert lab support for rare disease research with bioanalytical testing, biomarkers, and specialty assays to accelerate novel therapy development.
Providing advanced cell therapy bioanalysis with validated assays, regulatory expertise, and clinical trial support to accelerate development.
Expert immunology and inflammation support—custom assays, biomarker analysis, and validated solutions for clinical trials across therapeutic areas.
Neurology expertise for clinical trials - biomarker discovery, neuroinflammation profiling, PK/PD analysis, and custom assay development.
Providing specialized vaccine testing and bioanalysis with integrated services to support safety, efficacy, and global development.
We offer specialized gene therapy bioanalysis with validated assays, molecular expertise, and regulatory support to advance development.
Expert bioanalysis for biologics and gene and cell therapies, with trusted assays and regulatory-compliant data.
Extensive experience and scientific depth in oncology research, supporting the development of innovative cancer therapies across all phases of clinical trials.
Explore our biomarker solutions for clinical trials - supporting drug development, diagnostics, and personalized medicine strategies.
Accelerate clinical trials with custom assay development and validation -tailored solutions for biomarker, molecular, and immunoassay needs.
Reliable immunogenicity testing for clinical trials: ADA, Nab, & T-cell assays to assess immune response and support regulatory submissions.
Comprehensive PK/TK services for clinical trials: accurate drug absorption, distribution, metabolism, & toxicity profiling you can trust.
Accelerate biosimilar development with expert analytical support—comparability, characterization, and regulatory-ready data solutions.
Comprehensive gene expression assay solutions for clinical trials—accurate quantification, biomarker analysis, and transcriptomic insights.
Expert PBMC isolation services for clinical trials: high-quality cell separation, viability, & recovery for downstream immunological assays.
Advanced respiratory pathogen testing for clinical trials—accurate detection, quantification, and monitoring of viral and bacterial targets.
Delivering robust cell-based assay solutions for clinical trials—functional, potency, and mechanism-of-action testing tailored to your needs.
Comprehensive DNA/RNA analysis, biomarker discovery, and precision medicine insights for clinical trials.
End-to-end PCR solutions for clinical trials—conventional PCR, RT-qPCR, and ddPCR for sensitive, high-throughput nucleic acid detection and analysis.
High-quality sequencing assay services for clinical trials—NGS, targeted panels, and custom solutions for genomic, transcriptomic, and pathogen analysis.
Comprehensive cell culture services, including assay development, PBMC isolation, and support for preclinical and clinical studies.
Expert ligand binding and immunoassay services for biologics, vaccines, and biosimilars with validated ELISA, MSD, ECL, and multiplex platforms.
Advanced molecular testing using PCR, qPCR, & sequencing for sensitive detection & quantification to support clinical & preclinical studies.
High‑sensitivity ELISpot assays to measure antigen‑specific cellular immune responses for vaccine, immunology, & infectious disease studies.
State‑of‑the‑art instrumentation platforms delivering precise, high‑throughput biomarker analysis for clinical and preclinical studies.
End-to-end PCR solutions for clinical trials: PCR, RT-qPCR, & ddPCR for sensitive, high-throughput nucleic acid detection and analysis.
Multiparameter flow cytometry for detailed immune profiling, phenotyping, & biomarker analysis to support preclinical and clinical studies.
Cutting‑edge mass spectrometry workflows designed for challenging analytes, rigorous validation, and regulatory‑ready data.
Insights, industry trends, and scientific perspectives to help you navigate challenges in clinical development and biomarker testing.
Expert conversations on emerging science, clinical trial challenges, and innovations shaping the future of drug development.
On‑demand and live sessions featuring scientific experts discussing key topics in molecular testing, bioanalysis, and clinical trials.
Quick, easy‑to‑read overviews of our services, capabilities, and technical expertise to support your program planning.
Scientific posters from leading conferences highlighting our latest data, methods, and research contributions.
In‑depth technical papers exploring complex challenges, emerging technologies, and best practices in bioanalytical and molecular science.
Real‑world examples showcasing how our scientific strategy, technology, and partnership drive successful study outcomes.
Peer‑reviewed articles authored by our scientists, covering advanced methods, clinical insights, and breakthrough discoveries.
Specialized bioanalytical services – accurate, validated assays for drug development, biomarker analysis, and regulatory support.
End-to-end clinical trial supply solutions—packaging, labeling, storage, and global distribution of Investigational Medicinal Products (IMPs) and Advanced Therapy Medicinal Products (ATMPs).
Offering advanced bioinformatics services to transform complex data into actionable insights for drug development and precision medicine.
Collaborative pathology services for clinical trials—expertise in women’s health, urology, oncology, and integrated regulatory support.
Global central laboratory services—specialized testing, logistics, and data management to support Phase I–IV clinical trials with precision.
Specialty testing services for clinical trials—expert sample analysis, method transfer, assay development, and validation for reliable results.
Reliable data management for clinical trials—secure sample analysis, method transfer, assay development, validation, and regulatory compliance.
Secure sample management: traceable, temperature-controlled solutions with global logistics and long-term clinical trial support.
Expert project management for clinical trials—coordinating sample analysis, method transfer, assay development, validation, and timelines.
Robust quality systems and LIMS platforms ensure secure, compliant, and high-quality data for every phase of clinical trial research.
View in a different locale / language
In the world of bioanalytical PCR testing, validation is more than a regulatory checkbox—it’s the foundation of data integrity. Two key approaches—core validation and full process validation—offer distinct pathways to ensure assay performance, each tailored to different stages of development and regulatory needs.
Core validation focuses on the essential analytical components of the PCR assay. It evaluates the assay’s ability to detect and quantify the target under controlled conditions, ensuring specificity, sensitivity, and precision.
Full process validation goes further. It encompasses the entire workflow—from sample extraction and preparation to data analysis—ensuring every step meets rigorous quality and regulatory standards.
Core validation is ideal during the development or optimization of a new PCR assay, early-stage research, or exploratory studies. It supports internal decision-making and RUO (Research Use Only) applications, and is useful for evaluating safety or early efficacy when results do not directly impact treatment decisions. The key benefits include faster turnaround, lower resource requirements, and a focus on assay fundamentals like LOD, linearity, and specificity.
Full process validation is necessary when results will inform clinical or diagnostic decisions, be submitted to regulatory agencies, or must meet CLIA or other regulatory standards. It is also essential when inclusion/exclusion criteria or treatment decisions depend on the results. This approach offers comprehensive quality assurance, end-to-end validation of sample handling, equipment, and operator performance, and full regulatory readiness.
At Eurofins Clinical Trial Solutions, we offer both core and full process validation services tailored to your study’s needs and regulatory goals. Our global network of GCLP- and CLIA-compliant labs ensures your PCR assays are validated with precision, speed, and confidence.
We provide:
Whether you're in early assay development or preparing for regulatory submission, choosing between core and full process validation depends on your intended use. At Eurofins, we help you strike the right balance between speed, cost, and compliance—so you can move forward with clarity and confidence.
Our experts can help you determine whether core or full process validation is the best fit for your study and regulatory goals.